SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 31.03+0.1%3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Cacaito who wrote (16227)7/12/2003 1:40:56 PM
From: Bluegreen  Read Replies (2) of 17367
 
Which is worse Cacaito......allowing a Meningo. trial that allows several hours delay in giving Neuprex or conducting a trial that adds Raptiva to Methotrexate in RA? In my opinion giving Raptiva after patient is on Methotrexate is like asking someone to fine tune your TV after you have been banging on it with a hammer. AND MAKE NO MISTAKE ABOUT IT.......METHOTREXATE IS A BIG HAMMER.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext